Identification of docetaxel‐related biomarkers for prostate cancer
Sign Up to like & getrecommendations! Published in 2021 at "Andrologia"
DOI: 10.1111/and.14079
Abstract: Prostate cancer (PCa) which was the second commonly diagnosed malignancy, contributed to the top fifth carcinoma death in men. Nevertheless, the main chemotherapeutic agent docetaxel came to failure due to chemoresistance. Recently, increasing evidence suggested… read more here.
Keywords: immune infiltrating; identification docetaxel; prostate cancer; pca ... See more keywords